Fool.com
The World's Greatest Investing Community
Results 1 - 10 of 739 : 1 2 3 4 5 6 7 8 9 Next
A Big Upgrade for Gilead Sciences
This bullish call comes from more than just one analyst.
5-Star Stocks Poised to Pop: Gilead Sciences
Market-beating returns could be written in these five stars.
The Downside of Dollar-Cost Averaging
Remember the trend -- it's not always a friend of this approach.
More acquisitions already?
Let This Winning Combination Make You Wealthy
Dividend stocks that can grow are rare but valuable.Dividend stocks that can grow are rare but valuable.
These stocks have been looking up over the past month.
Looking for a good starting point? You've come to the right place.
This Just In: Upgrades and Downgrades
Needham suspends clinical trial of buying Geron.
Finally Convinced? Benlysta Works!
Human Genome Sciences succeeds where others have failed.
Small Savings Add Up to a Big Payoff
Slow and steady wins the race.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK